Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
Spinal muscular atrophy (SMA) is the most common genetic disease affecting infants and young adults. Due to mutation/deletion of the survival motor neuron (SMN) gene, SMA is characterized by the SMN protein lack, resulting in motor neuron impairment, skeletal muscle atrophy and premature death. Even...
Saved in:
Main Authors: | Giovanna Menduti (Author), Daniela Maria Rasà (Author), Serena Stanga (Author), Marina Boido (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEUROMUSCULAR JUNCTIONS AS KEY CONTRIBUTORS AND THERAPEUTIC TARGETS IN SPINAL MUSCULAR ATROPHY
by: Marina eBoido, et al.
Published: (2016) -
Spinal Muscular Atrophy Diagnosed by Newborn Screening
by: Matias Lopez-Chacon, et al.
Published: (2019) -
Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States
by: Craig M. Zaidman, et al.
Published: (2024) -
Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (1990) -
Innovating spinal muscular atrophy models in the therapeutic era
by: Ilaria Signoria, et al.
Published: (2023)